SCHEMBL5708679

SCHEMBL5708679

C=C[C]1OC(=O)C2C(C1=O)C2(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13349763 0.73 TP53 (0.32)
SCHEMBL8047574 0.73 TP53 (0.32)
SCHEMBL3381973 0.73 TP53 (0.32)
SCHEMBL8583750 0.63
SCHEMBL2698215 0.63 KDM4E (0.37)
SCHEMBL4353223 0.58
SCHEMBL911568 0.56 TP53 (0.50)
SCHEMBL910568 0.56 TP53 (0.50)
SCHEMBL12172563 0.54 TP53 (0.48)
SCHEMBL19557679 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0999209-B1 2-SULFAMOYLBENZOIC ACID DERIVATIVES KAKEN PHARMA CO LTD (JP) 2006-11-02 EP disclosed
US-20020049228-A1 2-Sulfamoylbenzoic acid derivatives KAKEN PHARMACEUTICALS 2002-04-25 US disclosed
US-6376671-B1 LEUKOTRIENE AND THROMBOXANE A2 ANTAGONISTIC AGENTS; ANTIALLERGIC AGENTS KAKEN PHARMACEUTICAL CO., LTD. (JP) 2002-04-23 US disclosed
US-6255321-B1 ANTIALLERGENS; RESPIRATRORY SYSTEM DISORDERS KAKEN PHARMACEUTICAL CO., LTD. (JP) 2001-07-03 US disclosed
EP-0999209-A1 2-SULFAMOYLBENZOIC ACID DERIVATIVES KAKEN PHARMACEUTICAL CO., LTD. (JP) 2000-05-10 EP disclosed